taxonomy (7)
protein (56)
source (20)
structure (25)
composition (1)
disease (6)
reference (25)
site (74)
peptide (58)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Gallus gallus (Chicken)
- SARS coronavirus CUHK-W1
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Afamin / Homo sapiens P43652
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Apolipoprotein B-100 / Homo sapiens P04114
- Apolipoprotein D / Homo sapiens P05090
- Asporin / Homo sapiens Q9BXN1
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens P98160
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- C-type mannose receptor 2 / Homo sapiens Q9UBG0
- Calumenin / Homo sapiens O43852
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- Ceruloplasmin / Homo sapiens P00450
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Complement factor h / Homo sapiens P08603
- Desmocollin-2 / Homo sapiens Q02487
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens Q13444
- Erythropoietin / Homo sapiens P01588
- Fibrillin-1 / Homo sapiens P35555
- Fibrinogen beta chain / Homo sapiens P02675
- Fibronectin / Homo sapiens P02751
- Glandular kallikrein 1 / Homo sapiens P06870
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Hepatocyte growth factor receptor / Homo sapiens P08581
- Histidine-rich glycoprotein / Homo sapiens P04196
- Immunoglobulin epsilon chain c region / Homo sapiens P01854
- Integrin alpha-L / Homo sapiens P20701
- Kallistatin / Homo sapiens P29622
- L-selectin / Homo sapiens P14151
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prosaposin / Homo sapiens P07602
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Serotransferrin / Homo sapiens P02787
- Teneurin-2 / Homo sapiens Q9NT68
- Thrombospondin-1 / Homo sapiens P07996
- Transmembrane 9 superfamily member 3 / Homo sapiens Q9HD45
- Uromodulin / Homo sapiens P07911
- Platelet glycoprotein IV / Bos taurus P26201
- Uncharacterized protein from Milk / Bos taurus
- Low density lipoprotein receptor-related protein 2 / Rattus norvegicus P98158
- Mrc ox-45 surface antigen / Rattus norvegicus P10252
- Uncharacterized protein / Rattus norvegicus
- Uncharacterized protein / Rattus norvegicus
- Uncharacterized protein / Rattus norvegicus
- Uncharacterized porcine zona pellucida glycoprotein / Sus scrofa
- Recombinant Spike glycoprotein (HEK293) - RBD domain / SARS coronavirus CUHK-W1 P59594
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Cerebrospinal Fluid (UBERON_0001359)
- Colon (UBERON_0001155)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Milk (UBERON_0001913) Plasma Membrane (GO_0005886)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Prefrontal Cortex (UBERON:0000451)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- Zona Pellucida (UBERON_0000086)
- 3Y1-B clone 1 (CVCL_4563)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293T (CVCL_0063)
- LS174T (CVCL_1384)
- RPMI-1788 (CVCL_2710) B-Lymphocyte (CL_0000236)
- Adipocytes (CL_0000136)
- Microsome (GO_0005792)
Source
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[GlcNAc(?1-?)]Man(a1-?)[Gal(?1-?)GlcNAc(?1-?)Man(a1-?)][GlcNAc(?1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GalNAc(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-4)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-4)[GalNAc(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-6)[GalNAc(b1-4)GlcNAc(b1-2)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-?)[GlcNAc(b1-?)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-?)[GlcNAc(b1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4) + GalNAc(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-?)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4) + GlcNAc(b1-?)"
- N-Linked / Complex / Structure 9620
- N-Linked / Complex / Structure 9663
- N-Linked / Complex / Structure 9791
- N-Linked / Complex / Structure 9794
- N-Linked / Complex / Structure 9865
- N-Linked / Complex / Structure 10166
- N-Linked / Complex / Structure 10283
- N-Linked / Complex / Structure 10305
- N-Linked / Complex / Structure 10528
- N-Linked / Complex / Structure 10740
- N-Linked / Complex / Structure 11573
- N-Linked / Complex / Structure 11761
- N-Linked / Complex / Structure 11770
Reported structure
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
Composition
- Alzheimer's disease (DOID:10652)
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- severe acute respiratory syndrome (DOID:2945)
Disease
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 (2021 - Cho BG, Gautam S, Peng W, Huang Y, Goli M, Mechref Y) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Spatial and temporal diversity of glycome expression in mammalian brain (2020 - Lee J, Ha S, Kim M, Kim SW, Yun J, Ozcan S, Hwang H, Ji IJ, Yin D, Webster MJ, Shannon Weickert C, Kim JH, Yoo JS, Grimm R, Bahn S, Shin HS, An HJ) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- A single glycan on IgE is indispensable for initiation of anaphylaxis (2015 - Kai-Ting C. Shade, Barbara Platzer, Nathaniel Washburn, Vinidhra Mani, Yannic C. Bartsch, Michelle Conroy, Jose D. Pagan, Carlos Bosques, Thorsten R. Mempel, Edda Fiebiger, Robert M. Anthony) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Carbohydrate structures of soluble human L-selectin recombinantly expressed in baby-hamster kidney cells. (2000 - Gohlke M, Mach U, Nuck R, Zimmermann-Kordmann M, Grunow D, Fieger C, Volz B, Tauber R, Petri T, Debus N, Reutter W) / Status : Reviewed
- Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties. (2000 - Cointe D, Bliard R, Jorieux S, Leroy Y, Glacet A, Verbert A, Bourel D, Chirat F) / Status : Reviewed
- Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney. (2000 - Morelle W, Haslam S, Ziak M, Roth J, Morris H, Dell A) / Status : Reviewed
- Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells. (1999 - Rudd P, Wormald M, Harvey D, Devasahayam M, McAlister M, Brown M, Davis S, Barclay A, Dwek R) / Status : Reviewed
- Structural elucidation of a variety of GalNAc-containing N-linked oligosaccharides from human urinary kallidinogenase. (1993 - Tomiya N, Awaya J, Kurono M, Hanzawa H, Shimada I, Arata Y, Yoshida T, Takahashi N) / Status : Reviewed
- Most bovine milk fat globule membrane glycoproteins contain asparagine-linked sugar chains with GalNAc beta 1-->4GlcNAc groups. (1993 - Sato T, Furukawa K, Greenwalt D, Kobata A) / Status : Reviewed
- Structural study of the sugar chains of CD36 purified from bovine mammary epithelial cells: occurrence of novel hybrid-type sugar chains containing the Neu5Ac alpha 2-->6GalNAc beta 1-->4GlcNAc and the Man alpha 1-->2Man alpha 1-->3Man alpha 1-->6Man groups. (1993 - Nakata N, Furukawa K, Greenwalt D, Sato T, Kobata A) / Status : Reviewed
- Neutral oligosaccharide structures linked to asparagines of porcine zona pellucida glycoproteins. (1991 - Mori E, Takasaki S, Hedrick J, Wardrip N, Mori T, Kobata A) / Status : Reviewed
- Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells. (1990 - Hiraizumi S, Takasaki S, Shiroki K, Kochibe N, Kobata A) / Status : Reviewed
Reference
- Afamin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Asporin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- Calumenin / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- Ceruloplasmin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Erythropoietin / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibronectin / Homo sapiens
-
Glandular kallikrein 1 / Homo sapiens
- Undefined site
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Immunoglobulin epsilon chain c region / Homo sapiens
- Integrin alpha-L / Homo sapiens
- Kallistatin / Homo sapiens
-
L-selectin / Homo sapiens
- Undefined site
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prosaposin / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Serotransferrin / Homo sapiens
- Teneurin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Uromodulin / Homo sapiens
-
Platelet glycoprotein IV / Bos taurus
- Undefined site
-
Uncharacterized protein from Milk / Bos taurus
- Undefined site
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
Mrc ox-45 surface antigen / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized porcine zona pellucida glycoprotein / Sus scrofa
- Undefined site
-
Recombinant Spike glycoprotein (HEK293) - RBD domain / SARS coronavirus CUHK-W1
- Undefined site
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- QCVNLTTR (8aa)
- DIENFNSTQK (10aa)
- YETTNK (6aa)
- CIQANYSIMENGK (13aa)
- HAIHVSGTNGTKRF (14aa)
- FHAIHVSGTNGTKRF (15aa)
- GSNYTSK (7aa)
- AIVNFTR (7aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TFYWDFYTNR (10aa)
- TQSLLIVNNATNVVIK (16aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- NVTGFTGR (8aa)
- VCQDCPIIAPINDTR (15aa)
- FINDTMAVYEAK (12aa)
- IVDVNITSEGK (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DFQHIINR (8aa)
- VVIHPNYSQVDIGIIK (16aa)
- FHLANR (6aa)
- IGNWSAMPSCK (11aa)
- MIENGSISFIPTIR (14aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LNSSTIK (7aa)
- ITDIENGSIANIPR (14aa)
- IIQVVYIHSNNITK (14aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- LIDNNK (6aa)
- VFNATR (6aa)
- GEVFNATR (8aa)
- NATRF (5aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKK (33aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- AIPQPQNVTSIIGCTH (16aa)
- WNDSPCNQSLPSICK (15aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- LYQDVNCT (8aa)
- NNSYECDIPI (10aa)
- NMTLFSDLVAEK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFVT (8aa)
- IGIVNNT (7aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- LGPYANTTK (9aa)
- EAGNITTDGYEIIGK (15aa)
- FEVDSPVYNATWSASIK (17aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Erythropoietin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2194.0403)
- 3Y1-B clone 1 (CVCL_4563)
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Urine (UBERON_0001088)
-
Glandular kallikrein 1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
-
Platelet glycoprotein IV / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
-
Platelet glycoprotein IV / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
-
L-selectin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Urine (UBERON_0001088)
-
Glandular kallikrein 1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
-
Platelet glycoprotein IV / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Zona Pellucida (UBERON_0000086)
-
Uncharacterized porcine zona pellucida glycoprotein / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells. (1999 - Rudd P, Wormald M, Harvey D, Devasahayam M, McAlister M, Brown M, Davis S, Barclay A, Dwek R) / Status : Reviewed
- Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells. (1990 - Hiraizumi S, Takasaki S, Shiroki K, Kochibe N, Kobata A) / Status : Reviewed
-
Mrc ox-45 surface antigen / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
-
Uncharacterized protein from Milk / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Microsome (GO_0005792)
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Adipocytes (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- CHO (CVCL_0213)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- FPNIT (5aa)
- GEVFNATR (8aa)
- VFNATR (6aa)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Adipocytes (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Adipocytes (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2194.0403)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2194.0403)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2194.0403)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2194.0403)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[GlcNAc(?1-?)]Man(a1-?)[Gal(?1-?)GlcNAc(?1-?)Man(a1-?)][GlcNAc(?1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GalNAc(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-4)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-4)[GalNAc(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-6)[GalNAc(b1-4)GlcNAc(b1-2)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-?)[GlcNAc(b1-?)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-?)[GlcNAc(b1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4) + GalNAc(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-?)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4) + GlcNAc(b1-?)"
- N-Linked / Complex / Structure 9620
- N-Linked / Complex / Structure 9663
- N-Linked / Complex / Structure 9791
- N-Linked / Complex / Structure 9794
- N-Linked / Complex / Structure 9865
- N-Linked / Complex / Structure 10166
- N-Linked / Complex / Structure 10283
- N-Linked / Complex / Structure 10305
- N-Linked / Complex / Structure 10528
- N-Linked / Complex / Structure 10740
- N-Linked / Complex / Structure 11573
- N-Linked / Complex / Structure 11761
- N-Linked / Complex / Structure 11770
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Afamin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Asporin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- Calumenin / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Integrin alpha-L / Homo sapiens
- Kallistatin / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prosaposin / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Serotransferrin / Homo sapiens
- Teneurin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Uromodulin / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- QCVNLTTR (8aa)
- DIENFNSTQK (10aa)
- YETTNK (6aa)
- CIQANYSIMENGK (13aa)
- HAIHVSGTNGTKRF (14aa)
- FHAIHVSGTNGTKRF (15aa)
- GSNYTSK (7aa)
- AIVNFTR (7aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TFYWDFYTNR (10aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- NVTGFTGR (8aa)
- VCQDCPIIAPINDTR (15aa)
- FINDTMAVYEAK (12aa)
- IVDVNITSEGK (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DFQHIINR (8aa)
- VVIHPNYSQVDIGIIK (16aa)
- FHLANR (6aa)
- IGNWSAMPSCK (11aa)
- MIENGSISFIPTIR (14aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LNSSTIK (7aa)
- ITDIENGSIANIPR (14aa)
- IIQVVYIHSNNITK (14aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- LIDNNK (6aa)
- NATRF (5aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKK (33aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- AIPQPQNVTSIIGCTH (16aa)
- WNDSPCNQSLPSICK (15aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- LYQDVNCT (8aa)
- NNSYECDIPI (10aa)
- NMTLFSDLVAEK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFVT (8aa)
- IGIVNNT (7aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- LGPYANTTK (9aa)
- EAGNITTDGYEIIGK (15aa)
- FEVDSPVYNATWSASIK (17aa)
-
- Hex:5 HexNAc:6 dHex:1 / Undefined type
(avg mass : 2194.0403)
- HEK293 (CVCL_0045)
-
Recombinant Spike glycoprotein (HEK293) - RBD domain / SARS coronavirus CUHK-W1
- Undefined site
Source
Suggested structure
Reported glycosite
- Hex:5 HexNAc:6 dHex:1 / Undefined type
(avg mass : 2194.0403)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2194.0403)
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)